Hansa Biopharma interim report Jan-Sept 2021

/PRNewswire/ -- Hansa on track to achieve key 2021 objectives: Agreements on funding obtained in three countries; HTA submissions in ten countries; and...

Related Keywords

Norway ,Germany ,Milan ,Lombardia ,Italy ,United States ,Netherlands ,United Kingdom ,Israel ,Sweden ,Finland ,San Antonio ,Texas ,Switzerland ,France ,Spain ,German ,Scotland ,Hansa Biopharma ,Prnewswire Hansa ,Klaus Sindahl ,Donato Spota ,Katja Margell ,Therapies Council ,European Medicines Agency ,Langone Transplant Institute ,European Society For Organ Transplantation ,Head Of Corporate Communications ,Health Technology Assessment ,Marketing Authorization Applications ,Market Access ,Technology Assessment ,Authorization Application ,Organ Transplantation ,Glomerular Basement Membrane ,Controlled Trial ,New Therapies Council ,Transplant Institute ,Limb Girdle Muscular Dystrophy ,Great Place ,Thursday October ,Securities Markets ,Corporate Communications ,Report Bod ,Hansa Biopharma Ab ,